Table 1.

Baseline patient demographics

Characteristics*	ITT cohort (n = 64)
Median age (range), y	75 (61-89)
Male, n (%)	34 (53)
White, n (%)	58 (91)
ECOG PS, n (%)
0	27 (42)
1	23 (36)
2	14 (22)
Primary diagnosis
De novo AML, n (%)	36 (56)
Secondary AML, n (%)	28 (44)
Median marrow blasts (range)	38.5 (5-92)
Cytogenetics, n (%)†
Adverse	18 (28)
Intermediate	32 (50)
Favorable	2 (3)
Unclassified	9 (14)
Not available	3 (5)

^*Data cutoff was September 2016.

^†Cytogenetic risk centrally assessed and reported according to Cancer and Leukemia Group B criteria.